Bardot P, Vincent S, Fournier M, Hubaud A, Joint M, Tora L
Development. 2017; 144(20):3808-3818.
PMID: 28893950
PMC: 5650055.
DOI: 10.1242/dev.146902.
Peat T, Rhodes D, Vandegraaff N, Le G, Smith J, Clark L
PLoS One. 2012; 7(7):e40147.
PMID: 22808106
PMC: 3393750.
DOI: 10.1371/journal.pone.0040147.
Li Y, Larrimer A, Curtiss T, Kim J, Jones A, Baird-Tomlinson H
Influenza Other Respir Viruses. 2011; 3(5):241-51.
PMID: 21462401
PMC: 4940803.
DOI: 10.1111/j.1750-2659.2009.00095.x.
Kremb S, Helfer M, Heller W, Hoffmann D, Wolff H, Kleinschmidt A
Antimicrob Agents Chemother. 2010; 54(12):5257-68.
PMID: 20876377
PMC: 2981278.
DOI: 10.1128/AAC.00515-10.
Wu Y, Beddall M, Marsh J
Curr HIV Res. 2007; 5(4):394-402.
PMID: 17627502
PMC: 2366165.
DOI: 10.2174/157016207781024018.
Rev-dependent lentiviral expression vector.
Wu Y, Beddall M, Marsh J
Retrovirology. 2007; 4:12.
PMID: 17286866
PMC: 1797186.
DOI: 10.1186/1742-4690-4-12.
Linkage of reduced receptor affinity and superinfection to pathogenesis of TR1.3 murine leukemia virus.
Murphy S, Chung-Landers M, Honczarenko M, Gaulton G
J Virol. 2006; 80(9):4601-9.
PMID: 16611920
PMC: 1472024.
DOI: 10.1128/JVI.80.9.4601-4609.2006.
Analysis of human immunodeficiency virus cytopathicity by using a new method for quantitating viral dynamics in cell culture.
Speirs C, van Nimwegen E, Bolton D, Zavolan M, Duvall M, Angleman S
J Virol. 2005; 79(7):4025-32.
PMID: 15767404
PMC: 1061548.
DOI: 10.1128/JVI.79.7.4025-4032.2005.
Persistent infection with primate foamy virus type 1 increases human immunodeficiency virus type 1 cell binding via a Bet-independent mechanism.
Schiffer C, Lecellier C, Mannioui A, Felix N, Nelson E, Lehmann-Che J
J Virol. 2004; 78(20):11405-10.
PMID: 15452263
PMC: 521848.
DOI: 10.1128/JVI.78.20.11405-11410.2004.
Cytopathic killing of peripheral blood CD4(+) T lymphocytes by human immunodeficiency virus type 1 appears necrotic rather than apoptotic and does not require env.
Lenardo M, Angleman S, Bounkeua V, Dimas J, Duvall M, Graubard M
J Virol. 2002; 76(10):5082-93.
PMID: 11967324
PMC: 136142.
DOI: 10.1128/jvi.76.10.5082-5093.2002.
Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolates.
Tokunaga K, Greenberg M, Morse M, Cumming R, Lyerly H, Cullen B
J Virol. 2001; 75(15):6776-85.
PMID: 11435556
PMC: 114404.
DOI: 10.1128/JVI.75.15.6776-6785.2001.
Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: implication of protein kinase C-dependent pathway.
Badou A, Bennasser Y, Moreau M, Leclerc C, Benkirane M, Bahraoui E
J Virol. 2000; 74(22):10551-62.
PMID: 11044099
PMC: 110929.
DOI: 10.1128/jvi.74.22.10551-10562.2000.
Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants.
Mosier D, Picchio G, Gulizia R, Sabbe R, Poignard P, Picard L
J Virol. 1999; 73(5):3544-50.
PMID: 10196243
PMC: 104126.
DOI: 10.1128/JVI.73.5.3544-3550.1999.
Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway.
Yang X, Gabuzda D
J Virol. 1999; 73(4):3460-6.
PMID: 10074203
PMC: 104113.
DOI: 10.1128/JVI.73.4.3460-3466.1999.
Coresistance to zidovudine and foscarnet is associated with multiple mutations in the human immunodeficiency virus type 1 reverse transcriptase.
Tachedjian G, French M, Mills J
Antimicrob Agents Chemother. 1998; 42(11):3038-43.
PMID: 9797252
PMC: 105992.
DOI: 10.1128/AAC.42.11.3038.
Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus.
MEANS R, Greenough T, Desrosiers R
J Virol. 1997; 71(10):7895-902.
PMID: 9311879
PMC: 192146.
DOI: 10.1128/JVI.71.10.7895-7902.1997.
1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity.
Daluge S, Good S, Faletto M, Miller W, St Clair M, BOONE L
Antimicrob Agents Chemother. 1997; 41(5):1082-93.
PMID: 9145874
PMC: 163855.
DOI: 10.1128/AAC.41.5.1082.
Investigation of the formation and intracellular stability of purine.(purine/pyrimidine) triplexes.
Debin A, Malvy C, Svinarchuk F
Nucleic Acids Res. 1997; 25(10):1965-74.
PMID: 9115364
PMC: 146673.
DOI: 10.1093/nar/25.10.1965.
An in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine.
Hooker D, Tachedjian G, Solomon A, Gurusinghe A, Land S, Birch C
J Virol. 1996; 70(11):8010-8.
PMID: 8892925
PMC: 190874.
DOI: 10.1128/JVI.70.11.8010-8018.1996.
Human immunodeficiency virus type 1 drug susceptibility determination by using recombinant viruses generated from patient sera tested in a cell-killing assay.
Boucher C, Keulen W, van Bommel T, Nijhuis M, de Jong D, de Jong M
Antimicrob Agents Chemother. 1996; 40(10):2404-9.
PMID: 8891152
PMC: 163542.
DOI: 10.1128/AAC.40.10.2404.